Roadzen Inc. — Form 10-Q summary
Reporting period: Quarter and nine months ended December 31, 2023. The statements are unaudited. Roadzen completed its business combination on September 20, 2023; Roadzen (DE) is the accounting acquirer, so prior-period comparisons principally reflect Roadzen (DE), while current-period results also include acquired businesses.
Financial performance
| Metric | Three months ended Dec. 31 | Nine months ended Dec. 31 |
|---|---|---|
| Revenue, 2023 | $15.64 million | $36.72 million |
| Revenue, 2022 | $3.32 million | $8.55 million |
| Operating loss, 2023 | $31.32 million | $42.75 million |
| Net loss attributable to Roadzen, 2023 | $30.57 million | $65.69 million |
| Net loss per share, 2023 | $0.45 | $1.82 |
| Operating cash flow, 2023 | Not separately provided in the filing summary for the quarter | $(14.58) million |
Quarterly revenue increased 372% year over year; nine-month revenue increased 329%. Management attributed much of the reported growth to acquisitions: GIM and NAC contributed approximately $9.0 million of quarterly growth and $20.8 million of nine-month growth, while FAP contributed $0.8 million for the nine-month period. Management also reported organic growth of 92% for the quarter and 83% for the nine months.
Revenue for the quarter comprised $8.16 million from commissions and distribution and $7.48 million from Insurance-as-a-Service (IaaS). For the nine months, the respective amounts were $17.62 million and $19.11 million. Cost of services was $6.82 million for the quarter and $15.67 million for the nine months. The resulting gross profit before depreciation and amortization was approximately $8.82 million and $21.06 million, respectively.
Operating expenses rose substantially, particularly general and administrative expense, which was $26.68 million for the quarter and $34.86 million for the nine months. The filing attributes much of the increase to stock-based compensation, including $27.25 million in the quarter and $30.78 million for the nine months. Nine-month fair-value losses on financial instruments were $22.37 million, versus $1.01 million in the prior-year period; the quarter recorded a $1.22 million fair-value gain, versus a $4.02 million gain a year earlier. Adjusted EBITDA, a non-GAAP measure, was a loss of $3.10 million for the quarter and $8.23 million for the nine months.
Financial position and liquidity
At December 31, 2023, cash and cash equivalents were $9.41 million, plus $0.43 million of restricted cash. Current assets were $52.93 million and current liabilities were $66.17 million, implying negative working capital of approximately $13.24 million. Current assets included a $24.46 million forward purchase agreement asset and $7.14 million of net accounts receivable.
Total borrowings were approximately $18.17 million: $15.17 million short-term, $2.39 million current maturities of long-term borrowings, and $0.61 million long-term. Short-term borrowings included $7.5 million of senior secured notes bearing 15% interest and maturing June 30, 2024. Certain secured debentures carried rates of 19.25%–20.00%, with maturities beginning January 2024. The company also reported $8.87 million due to an insurer. Total liabilities were $67.95 million; accumulated deficit was $117.03 million.
Nine-month cash used in operations was $14.58 million, compared with $6.97 million in the prior-year period. Cash used in investing was $6.67 million, including $5.75 million for acquisitions. Financing provided $18.60 million, primarily from borrowings and preferred-stock proceeds. Management expects continued operating losses and negative operating cash flows and says additional capital may be needed. The filing states management believes available funding is sufficient to alleviate substantial doubt about the company’s ability to continue as a going concern for 12 months from authorization of the financial statements, while also noting reliance on existing and potential investors.
Material changes, outlook and risks
- Business combination and acquisitions: The September 2023 business combination completed the transition to a public company. During 2023, Roadzen acquired GIM, NAC and FAP, expanding its UK, U.S. and Indian operations. Management describes a strategy centered on insurance distribution and its IaaS platform; it expects continued investment in sales and marketing and higher absolute general and administrative costs as a public company.
- Forward purchase agreement: The agreement is carried at fair value using Level 3 inputs. The filing reports a $24.46 million asset at December 31, 2023, and a $4.15 million fair-value gain during the quarter. The company received $2.29 million from the seller during the quarter. Fair-value changes contributed to significant nine-month earnings volatility.
- Stock-based compensation and dilution: The company reported 9.90 million unvested RSUs and approximately $76.78 million of unrecognized compensation expense expected to be recognized over a weighted-average period of about nine months. It also reported 19.16 million public and private placement warrants outstanding, generally exercisable at $11.50 per share. Potential dilution and future compensation expense merit attention.
- UK regulatory risk: In February 2024, the UK FCA directed insurers, including Roadzen’s insurance partner, to temporarily stop selling Guaranteed Asset Protection (GAP) products pending regulatory resubmission and approval. Management warns that delays or unfavorable outcomes could materially affect revenue, profitability and customer relationships.
- Other risks: One customer represented 33% of quarterly revenue. The company cites capital-raising needs, regulatory compliance in India, the UK and California, technology and data-security risks, and exposure to foreign exchange. It reported no material pending legal proceedings. Management concluded disclosure controls were effective as of December 31, 2023.
- Guidance: The filing provides no numerical revenue or earnings guidance. Management expects ongoing losses and negative operating cash flows for an extended period.
Investor verification priorities
- Assess whether acquisition-driven growth is translating into sustainable organic growth and improved operating leverage.
- Review cash runway, near-term debt maturities, borrowing costs, negative working capital and the company’s ability to obtain additional financing.
- Examine the forward purchase agreement’s settlement terms, fair-value assumptions and cash impact; distinguish the reported asset and proceeds from cash actually available to the company.
- Track the FCA’s GAP product review and any effects on Roadzen’s UK revenue, margins and customer retention.
- Evaluate the scale and timing of RSU expense, potential share dilution from RSUs and warrants, and the impact of concentrated customer revenue.